News

Krebs Biochemicals & Industries Limited informed the BSE Limited and National Stock Exchange of India Ltd that trading window for dealings in securities of the company will be closed from the close of business hours on September 30, 2026, until 48 hours after the declaration of unaudited financial results for the second quarter and half year ended September 30, 2026, for promoters, directors, designated persons, their immediate relatives and all connected persons.

Net Loss of Krebs Biochemicals & Industries reported to Rs 2.48 crore in the quarter ended June 2026 as against net loss of Rs 5.32 crore during the previous quarter ended June 2025. Sales rose 27.37% to Rs 6.98 crore in the quarter ended June 2026 as against Rs 5.48 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales6.985.48 27 OPM %11.89-37.96 - PBDT-0.89-3.72 76 PBT-2.48-5.32 53 NP-2.48-5.32 53 Powered by Capital Market - Live News

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 6 August 2026.

Net Loss of Krebs Biochemicals & Industries reported to Rs 2.34 crore in the quarter ended March 2026 as against net loss of Rs 8.27 crore during the previous quarter ended March 2025. Sales rose 11.64% to Rs 6.81 crore in the quarter ended March 2026 as against Rs 6.10 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 16.93 crore in the year ended March 2026 as against net loss of Rs 26.94 crore during the previous year ended March 2025. Sales declined 45.21% to Rs 23.73 crore in the year ended March 2026 as against Rs 43.31 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales6.816.10 12 23.7343.31 -45 OPM %-12.63-88.69 --22.97-34.70 - PBDT-0.77-6.68 88 -10.51-20.23 48 PBT-2.34-8.25 72 -16.93-26.92 37 NP-2.34-8.27 72 -16.93-26.94 37 Powered by Capital Market - Live News

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 21 May 2026.